- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03602326
Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective
July 18, 2018 updated by: Gokhan Yazici
Early term rehabilitation initiated after stroke should be based on motor learning principles and neural plasticity.
To achieve motor learning and neural plasticity, exercises consisting of intense and repetitive training should be given according to the patients' functional level.
The neurodevelopmental treatment-Bobath (NDT_B) approach is based on motor learning principles.
In literature, studies that show the early term effects of NDT-B on functional recovery are inadequate.
The aim of this study was to investigate the effects NDT-B applied in the early term of stroke, on postural control, functional movement, balance and activities of daily living.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
When literature is examined, it can be seen that evidence is limited.
Studies investigating the effects of the Bobath Approach in the early term in stroke, state that NDT-B is reliable and feasible.
However none of these studies have examined the effects of NDT-B in acute term stroke on functionality and daily living.
Additionally, in all of these studies it was also stated that further studies should be conducted.
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06560
- Gazi University Hospital, Department of Neurology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients older than 18 years of age
- Systolic blood pressure between 120 and 220 mmHg
- Oxygen saturation >92% (with or without O2 support)
- A heart rate of 40 to 100 beats/min
- A body temperature of <38.5°C
- A disability level of ≤4 according to the Modified Rankin Scale
- Those who could respond to verbal commands
Exclusion Criteria:
- A history of previous stroke
- Concomitant progressive neurological disturbances
- Acute coronary disease
- Severe heart failure
- Concomitant rheumatologic diseases
- A fracture or an acute orthopedic disorder that would prevent mobilization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neurodevelopmental Therapy-Bobath group
Bobath Approach Principles and exercises will be performed 5 days a week with physical therapists and everyday with caregivers.
Physiotherapy will be initiated as early as possible according to the principles of the method by experienced NDT-B therapists.
Exercises will be implemented according to the patients' status and will be used to maintain and improve muscle strength and endurance.
Both the unaffected and affected side will be included in rehabilitation.
The exercises given are designed to be simple, understandable, task-oriented and repetitive, in accordance with the Bobath approach and the functional state of the patient at that time.
In order to prevent motor amnesia and neglect of the affected side, correct positioning and sensory input will be provided since the first session.
|
Neurodevelopmental Therapy-Bobath (NDT-B) is one of the most commonly used models for therapeutic management and treatment in patients with stroke.
The basic philosophy underlying this approach is that; lesions in the central nervous system cause impairments in the coordination of movement and posture combined with problems in muscle tone which lead directly to functional limitations.
According to the NDT-B approach, practice has a great role in treatment due to the fact that more practice leads to better motor learning and increases neural plasticity.
According to NDT-B, the duration of treatment should not be limited to rehabilitation sessions, but should be designed to be implied throughout the day and should be adapted to the patients' daily life.
|
|
Active Comparator: Standart Rehabilitation Group (SR group)
Patients will be included in standard rehabilitation sessions, 5 days per week.
The rehabilitation sessions will be performed by standard clinical physiotherapists according to the hospital routine.
The rehabilitation program will consist of in-bed joint range of motion exercises and bedside mobilization applications.
The patients will be included in the rehabilitation program as early as possible and the program will continue until the patients are discharged
|
Standard Rehabilitation for Stroke consists of the hospitals' physiotherapy and rehabilitation routine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Stroke Rehabilitation Assessment of Movement Scale
Time Frame: Change from Baseline functional movements at 10 days
|
The Stroke Rehabilitation Assessment of Movement Scale (STREAM) was used to assess functional movements and mobility.
The scale consists of two subsections and a total of 30 tests evaluating the performance and the quality of the individual's voluntary limb movements (20 tests) and basic mobility activities (10 tests).
The total score will be used for assessment in this study.
The total score is 70.
A high score indicates less motor impairment, while a lower score indicates increased motor impairment.
|
Change from Baseline functional movements at 10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Trunk Impairment scale
Time Frame: Change from Baseline sitting balance and postural control at 10 days
|
The Trunk Impairment scale (TIS) was used to assess sitting balance and postural control.
TIS consists of 3 sections and 17 tests evaluating static-dynamic sitting balance and coordination.
The total score will be used for assessment in this study.
The total score is 23.
A higher score indicates better control of the trunk, while a lower score indicates poor postural trunk control.
|
Change from Baseline sitting balance and postural control at 10 days
|
|
The Functional Ambulation Classification
Time Frame: Change from Baseline level of functional ambulance at 10 days
|
The Functional Ambulation Classification (FAC) is a method for classifying gait mobility in neurologically impaired patients.
The FAC has six categories ranging from 0 to 5. A higher score indicates independence in ambulation, while a lower score indicates the person has non-functional ambulation.
This 6-point scale assesses ambulation status by determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device.
|
Change from Baseline level of functional ambulance at 10 days
|
|
The Berg Balance Scale
Time Frame: Change from Baseline functional balance at 10 days
|
The Berg Balance Scale (BBS) was used to assess functional balance.
BBS consists of 14 tests evaluating balance during; postural changes, at different positions and during movement.
Each test is rated from 0 to 4. The total score will be used for assessment in this study.
The highest score is 56; 0-20 point indicates a balance disorder (high risk of falls), 21-40 points indicates an acceptable balance (moderate risk of falls), 41-56 points indicates good balance (low risk of falling)
|
Change from Baseline functional balance at 10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gokhan Yazici, Ph.D., Gazi University, Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation, Ankara, Turkey
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Actual)
July 6, 2018
Study Completion (Actual)
July 13, 2018
Study Registration Dates
First Submitted
July 5, 2018
First Submitted That Met QC Criteria
July 18, 2018
First Posted (Actual)
July 26, 2018
Study Record Updates
Last Update Posted (Actual)
July 26, 2018
Last Update Submitted That Met QC Criteria
July 18, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 196
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
University of CalgaryThe George Institute for Global Health, AustraliaRecruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingStroke | Stroke Gait Rehabilitation | Stroke Ischemic | Balance Deficits | Stroke (CVA) or Transient Ischemic AttackUnited States
-
University of MiamiNo longer availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Jagiellonian UniversityCompletedStroke, Ischemic | Subacute StrokePoland
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Hyogo Medical UniversityRecruitingAcute Ischemic Stroke | Endovascular Therapy | Acute Ischemic Stroke (AIS) Related to a Distal OcclusionJapan
Clinical Trials on Neurodevelopmental Therapy-Bobath group
-
Marmara UniversityUnknown
-
Tuba Derya DoğanNot yet recruitingCerebral Palsy | Cerebral Palsy Early Intervention
-
Pamukkale UniversityCompletedHemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Turkey
-
Wroclaw University of Health and Sport SciencesNot yet recruitingSpastic Diplegia Cerebral Palsy | Spastic HemiplegiaPoland
-
Escola Superior Saúde Fernando PessoaActive, not recruiting
-
Hacettepe UniversityCompletedBrain Neoplasms | Stroke, AcuteTurkey
-
Marmara UniversityCompletedCerebral Palsy | Developmental Disability | Development, Infant | Motor Disorders | PrematureTurkey
-
Istanbul Arel UniversityCompleted
-
University of ThessalyNot yet recruiting